Northeast Financial Consultants’s Ironwood Pharmaceuticals IRWD Stock Holding History

Northeast Financial Consultants’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-37,355	Closed	-$386K	–	305
2020 Q2	$386K	Hold	37,355	–	–	0.04%	192
2020 Q1	$377K	Hold	37,355	–	–	0.04%	183
2019 Q4	$497K	Sell	37,355 -140,100	-79%	-$1.54M	0.04%	184
2019 Q3	$1.52M	Hold	177,455	–	–	0.16%	96
2019 Q2	$1.94M	Sell	177,455 -34,426	-16%	-$386K	0.2%	81
2019 Q1	$2.4M	Buy	+211,881	New	+$2.37M	0.27%	62

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Northeast Financial Consultants's IRWD Position: Q3 2020 in Review

Northeast Financial Consultants sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 37,355 shares — an estimated $386K sold.

Northeast Financial Consultants first reported a position in IRWD in Q1 2019 and held it in 6 quarters. The position peaked at $2.4M in Q1 2019. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

Northeast Financial Consultants reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Northeast Financial Consultants sold 37,355 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $386K.
Northeast Financial Consultants first reported a position in Ironwood Pharmaceuticals in Q1 2019 and held it in 6 quarters.
Northeast Financial Consultants's Ironwood Pharmaceuticals position peaked at $2.4M in Q1 2019.
190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on Northeast Financial Consultants's 13F filing for Q3 2020, filed 29 Oct 2020.